Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Q Liu

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometryDavid Q Liu, Bindhu V Karanam, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterasesBindhu V Karanam, Cornelis E C A Hop, David Q Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogsMaria G Beconi, James R Reed, Yohannes Teffera, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-phenyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometryDavid Q Liu, Bindhu V Karanam, George A Doss, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 21, 2004
In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterasesBindhu V Karanam, Cornelis E C A Hop, David Q Liu, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogsMaria G Beconi, James R Reed, Yohannes Teffera, et al.
Pageof 4